PARAMETRIC PORTFOLIO ASSOCIATES LLC - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 216 filers reported holding CANTEL MEDICAL CORP in Q2 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$3,763,000
-6.0%
47,131
-7.2%
0.00%0.0%
Q4 2020$4,004,000
+31.3%
50,767
-26.8%
0.00%0.0%
Q3 2020$3,049,000
-5.9%
69,396
-5.3%
0.00%0.0%
Q2 2020$3,240,000
-5.7%
73,262
-23.5%
0.00%
-33.3%
Q1 2020$3,437,000
-54.5%
95,732
-10.1%
0.00%
-50.0%
Q4 2019$7,551,000
-13.1%
106,502
-8.3%
0.01%
-14.3%
Q3 2019$8,691,000
-5.4%
116,190
+2.0%
0.01%
-12.5%
Q2 2019$9,188,000
+41.6%
113,941
+17.5%
0.01%
+33.3%
Q1 2019$6,488,000
+7.0%
96,994
+19.1%
0.01%0.0%
Q4 2018$6,066,000
-24.0%
81,473
-6.0%
0.01%
-14.3%
Q3 2018$7,981,000
-18.8%
86,697
-13.3%
0.01%
-22.2%
Q2 2018$9,832,000
+11.4%
99,958
+26.1%
0.01%0.0%
Q1 2018$8,829,000
+9.2%
79,246
+0.9%
0.01%
+12.5%
Q4 2017$8,082,000
+35.1%
78,564
+23.6%
0.01%
+33.3%
Q3 2017$5,984,000
+29.4%
63,548
+7.0%
0.01%0.0%
Q2 2017$4,626,000
-52.0%
59,370
-50.6%
0.01%
-60.0%
Q1 2017$9,634,000
+93.8%
120,271
+90.5%
0.02%
+114.3%
Q4 2016$4,971,000
-12.0%
63,122
-12.9%
0.01%
-12.5%
Q3 2016$5,650,000
+2.4%
72,453
-9.7%
0.01%
-11.1%
Q2 2016$5,517,000
+5.5%
80,272
+9.6%
0.01%
+12.5%
Q1 2016$5,227,000
+20.5%
73,243
+4.9%
0.01%
+14.3%
Q4 2015$4,339,000
+39.2%
69,830
+27.1%
0.01%
+16.7%
Q3 2015$3,116,000
+8.4%
54,948
+2.6%
0.01%0.0%
Q2 2015$2,875,000
+26.2%
53,576
+11.7%
0.01%
+20.0%
Q1 2015$2,279,000
+3.2%
47,976
-6.0%
0.01%0.0%
Q4 2014$2,208,000
+33.8%
51,043
+6.3%
0.01%
+25.0%
Q3 2014$1,650,000
-8.2%
47,999
-2.2%
0.00%0.0%
Q2 2014$1,797,000
+29.2%
49,083
+19.0%
0.00%
+33.3%
Q1 2014$1,391,000
-14.3%
41,240
-13.8%
0.00%
-25.0%
Q4 2013$1,623,000
+17.5%
47,865
+10.4%
0.00%0.0%
Q3 2013$1,381,000
+39.6%
43,352
+48.4%
0.00%
+33.3%
Q2 2013$989,00029,2110.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q2 2017
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders